Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR3 | P49019 | 3/20 | 0.66 |
| ▸ | NNMT | P40261 | 2/20 | 0.53 |
| ▸ | CCR6 | P51684 | 1/20 | 0.47 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.44 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.44 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.44 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.44 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.44 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.44 |
| ▸ | PRKAG3 | Q9UGI9 | 1/20 | 0.44 |
| ▸ | PRKAG2 | Q9UGJ0 | 1/20 | 0.44 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.44 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | SYK | P43405 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1937458 | 0.85 | HCAR3 (0.65) | HCAR3NNMTCCR6KCNQ3KCNQ2 | |
| SCHEMBL1937459 | 0.85 | HCAR3 (0.65) | HCAR3NNMTCCR6KCNQ3KCNQ2 | |
| SCHEMBL17276030 | 0.84 | HCAR3 (0.72) | HCAR3NNMTCCR6PRKAB2PRKAG1 | |
| SCHEMBL1938176 | 0.81 | HCAR3 (0.59) | HCAR3NNMTCCR6 | |
| SCHEMBL13463628 | 0.81 | HCAR3 (0.58) | HCAR3NNMTCCR6KCNQ3KCNQ2 | |
| Hydrochloric Acid SCHEMBL2416614 | 0.80 | HCAR3 (0.57) | HCAR3NNMTCCR6 | |
| SCHEMBL1542481 | 0.80 | HCAR3 (1.00) | HCAR3KCNQ3KCNQ2PRKAB2PRKAG1 | |
| SCHEMBL16737383 | 0.79 | HCAR3 (0.56) | HCAR3DGAT1KCNH2SMN1; SMN2SYK | |
| SCHEMBL16737384 | 0.79 | HCAR3 (0.56) | HCAR3DGAT1KCNH2SMN1; SMN2SYK | |
| SCHEMBL3466282 | 0.79 | NNMT (0.58) | NNMTEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250313574-A1 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2025-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250313574-A1 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | NEU1, NEU2, NEU4 | HCAR3 492/4885NNMT 786/4885CCR6 2345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.